Skip to main content
. 2019 Feb 6;133(15):1652–1663. doi: 10.1182/blood-2018-11-883710

Table 3.

Multivariable analysis for factors that have an impact on EFS in patients who achieved MRD-negative CR, adjusted for HCT after CAR T-cell therapy as a time-dependent covariate

Variable Multivariable analysis P
HR 95% CI
LDH prelymphodepletion (per 100 U/L increment) 1.39 1.11-1.73 .004
Platelets prelymphodepletion (per 50 000/μL increment) 0.74 0.53-1.03 .069
Fludarabine added to lymphodepletion 0.25 0.15-0.78 .003
HCT after CAR T-cell therapy 0.39 0.13-1.15 .088